Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
CSL Behring Agrees to Acquire Novel Late-Stage Gene Therapy Candidate for Hemophilia B Patients from uniQure
Thursday, June 25, 2020Global biotherapeutics leader CSL Behring announced that it has agreed to acquire exclusive global license rights to commercialize an adenoassociated virus AAV gene therapy program AMT etranacogene dezaparvovec for the treatment of hemophilia B from...
Replicate Bioscience and Immunomic Therapeutics Form Collaboration to Combat Infectious Diseases and Cancers
Thursday, June 25, 2020Replicate Bioscience Inc a privatelyheld biopharmaceutical company creating novel treatments to prevent drug resistance in cancers and Immunomic Therapeutics Inc ITI a privatelyheld clinicalstage biotechnology company pioneering the study of nucleic...
Linnaeus Therapeutics Announces Clinical Trial Collaboration Agreement with Merck to Evaluate LNS8801
Wednesday, June 24, 2020Linnaeus Therapeutics Inc Linnaeus a privately held clinicalstage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics today announced that it has entered into a clinical collaborati...
Century Therapeutics Announces Acquisition of Empirica Therapeutics
Wednesday, June 24, 2020Century Therapeutics announced its acquisition of Empirica Therapeutics to leverage its iPSCderived allogeneic cell therapies against glioblastoma GBM
Agenus and Betta Pharmaceuticals Enter Into a License Agreement for Balstilimab and Zalifrelimab in Greater China
Tuesday, June 23, 2020Agenus Inc an immunooncology IO company with an extensive pipeline of agents designed to activate immune response to cancers announced today that it has entered into an agreement with Betta Pharmaceuticals SZ a top Chinese pharmaceutical company focu...
Sarepta Therapeutics and Codiak BioSciences Collaborate to Research and Develop Exosome-Based Therapeutics for Rare Diseases
Tuesday, June 23, 2020Sarepta Therapeutics Inc the leader in precision genetic medicine for rare diseases and Codiak BioSciences Inc a company at the forefront of advancing engineered exosomes as a new class of biologic medicines today announced a global research and opti...
Ascentage Pharma Enters Clinical Collaboration to Evaluate the Combination of Bcl-2 and BTK Inhibitors
Monday, June 22, 2020Ascentage Pharma HK a global clinicalstage biotechnology company engaged in developing novel therapies for cancers chronic hepatitis B CHB and senescence diseases today announced a clinical collaboration with Acerta Pharma the hematology research and...
Neurocline Biosciences and Takeda announce collaboration to develop and commercialize drug candidates for mental illness
Monday, June 22, 2020Neurocline Biosciences and Takeda Pharmaceutical Co Ltd announced a strategic collaboration to develop and commercialize compounds in the early to midstage development of Takedas pipeline for mental illness Specifically Takeda has monopolized Neurocl...
Ovid Therapeutics Receives FDA Rare Pediatric Disease Designation for OV101 for the Treatment of Angelman Syndrome
Saturday, June 20, 2020Ovid Therapeutics Inc a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases today announced that the US Food and Drug Administration FDA has granted Rare Pediatric Disease Des...
Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
Friday, June 19, 2020Alpine Immune Sciences Inc a leading clinicalstage immunotherapy company focused on developing innovative treatments for cancer and autoimmuneinflammatory diseases and AbbVie Inc NYSE ABBV a researchbased global biopharmaceutical company today annou...
